SCHEMBL626417

SCHEMBL626417

CC(=O)Nc1cc(-c2nc(I)c(C(=O)O)o2)c(C)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3C3 Q8NEB9 5/20 0.39
ABL1 P00519 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
PTK2 Q05397 1/20 0.36
CRBN Q96SW2 1/20 0.34
MAP4K1 Q92918 1/20 0.34
NSD2 O96028 1/20 0.33
NUDT1 P36639 1/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 1/20 0.33
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
FLT1 P17948 1/20 0.32
FLT4 P35916 1/20 0.32
KDR P35968 1/20 0.32
KMT2A Q03164 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL626235 0.89 ABL1 (0.37) PIK3C3ABL1L3MBTL1PTK2CRBN
SCHEMBL626666 0.87 KDM4E (0.39) PIK3C3ABL1L3MBTL1PTK2KDM4E
SCHEMBL626945 0.79 PIK3C3 (0.45) PIK3C3ABL1PTK2KDM4EFLT1
SCHEMBL626814 0.77 ABL1 (0.36) PIK3C3ABL1L3MBTL1PTK2CRBN
SCHEMBL624719 0.72 PIK3C3 (0.40) PIK3C3ABL1L3MBTL1PTK2CRBN
SCHEMBL626066 0.72 PIK3C3 (0.45) PIK3C3ABL1PTK2NSD2
SCHEMBL626067 0.71 PIK3C3 (0.42) PIK3C3ABL1PTK2KDM4EKMT2A
SCHEMBL626227 0.71 DGAT1 (0.31) ABL1
SCHEMBL9105855 0.70 KDM4E (0.39) PIK3C3ABL1KDM4EHSP90AA1HSP90AB1
SCHEMBL20861632 0.70 L3MBTL1 (0.53) PIK3C3ABL1L3MBTL1PTK2CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859768-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-10-14 US disclosed
US-8859768-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-10-14 US disclosed
US-8859768-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-10-14 US disclosed
EP-2603216-A1 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-06-19 EP disclosed
US-20120142732-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-06-07 US disclosed
US-20120142732-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-06-07 US disclosed
US-20120142732-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-06-07 US disclosed
WO-2012021615-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed
WO-2012021615-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142732-A1 HETEROARYLS AND USES THEREOF PIK3R4, PIK3C2B, PIK3R1 PIK3C3 52/4885ABL1 652/4885L3MBTL1 580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.